Post-translational modifications on the retinoblastoma protein

Related Experiment Video

Updated: Sep 21, 2025

Inducible and Reversible Dominant-negative DN Protein Inhibition
08:35

Inducible and Reversible Dominant-negative DN Protein Inhibition

Published on: January 7, 2019

8.5K

Linbin Zhou1, Danny Siu-Chun Ng1, Jason C Yam1,2

  • 1Department of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong, Hong Kong, China.

Journal of Biomedical Science
|June 1, 2022
PubMed

Insights

The retinoblastoma protein (pRb) regulates cell division and tumor suppression. Its functions are controlled by post-translational modifications (PTMs), and understanding these PTMs may lead to new disease treatments.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • The retinoblastoma protein (pRb) is a key cell cycle regulator and tumor suppressor, frequently altered in cancers.
  • Post-translational modifications (PTMs) like phosphorylation, ubiquitination, SUMOylation, acetylation, and methylation are critical for pRb function.
  • Dysregulated pRb PTMs are linked to abnormal cell proliferation and tumorigenesis.

Purpose of the Study:

  • To review recent findings on how individual PTMs affect pRb functions.
  • To explore the coordinated interplay (collaboration and competition) between different PTMs on pRb.
  • To highlight the therapeutic potential of understanding pRb post-translational modulation.

Main Methods:

  • Literature review of recent findings on pRb post-translational modifications.
  • Analysis of studies detailing individual PTMs on pRb.
  • Synthesis of information on the combinatorial effects of PTMs on pRb.

Main Results:

  • Individual PTMs significantly impact pRb's role in cell cycle control and tumor suppression.
  • PTMs on pRb can act collaboratively or competitively, influencing its overall function.
  • Altered PTM patterns are associated with various human diseases, particularly cancer.

Conclusions:

  • A comprehensive understanding of pRb PTMs and their coordination is essential for elucidating its regulatory mechanisms.
  • Targeting pRb PTMs offers promising avenues for developing novel therapeutic strategies.
  • Further research into pRb modulation could lead to advancements in treating human diseases.
Keywords:
AcetylationMethylationPhosphorylationRetinoblastomaSUMOylationUbiquitination

More Related Videos

In Vivo Detection and Analysis of Rb Protein SUMOylation in Human Cells09:40

In Vivo Detection and Analysis of Rb Protein SUMOylation in Human Cells

Published on: November 2, 2017

7.4K
Reconstruct Human Retinoblastoma In Vitro06:52

Reconstruct Human Retinoblastoma In Vitro

Published on: October 11, 2022

1.5K

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
7.5K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.2K
Protein Modifications in the RER01:26

Protein Modifications in the RER

Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
5.7K
Post-translational Translocation of Proteins to the RER01:27

Post-translational Translocation of Proteins to the RER

A sizable fraction of proteins destined for ER are first synthesized in the cell cytosol and then transported across the ER membrane–a process called post-translational translocation. Similar to cotranslationally translocated proteins, these proteins also use the Sec translocon complex to enter the ER lumen.
Targeting proteins to the ER
Hsp40 and Hsp70 chaperone molecules bind the translated proteins in the cytosol to prevent their folding. The chaperone binding helps to keep the signal...
6.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K